Cargando…

Circulating Tumor DNA Methylation Biomarkers for Characterization and Determination of the Cancer Origin in Malignant Liver Tumors

SIMPLE SUMMARY: Malignant liver tumors consist of primary tumors and metastases. A correct diagnosis can be achieved with different methods; one of them is the analysis of the cell-free DNA methylation profile in liquid biopsy, which allows for the detection, characterization, and determination of c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Draškovič, Tina, Zidar, Nina, Hauptman, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913861/ https://www.ncbi.nlm.nih.gov/pubmed/36765815 http://dx.doi.org/10.3390/cancers15030859

Ejemplares similares

Expression of Fibrosis-Related Genes in Liver and Kidney Fibrosis in Comparison to Inflammatory Bowel Diseases
por: Jerala, Miha, et al.
Publicado: (2022)

Characterization of DNA Methylation in Circulating Tumor Cells
por: Pixberg, Constantin F., et al.
Publicado: (2015)

Circulating microRNA Panels for Detection of Liver Cancers and Liver-Metastasizing Primary Cancers
por: Ranković, Branislava, et al.
Publicado: (2023)

Methylated circulating tumor DNA as a biomarker in cutaneous melanoma
por: Diefenbach, Russell J, et al.
Publicado: (2020)

Long Non-Coding RNAs as Potential Regulators of EMT-Related Transcription Factors in Colorectal Cancer—A Systematic Review and Bioinformatics Analysis
por: Pavlič, Ana, et al.
Publicado: (2022)

The integrative knowledge base for miRNA-mRNA expression in colorectal cancer
por: Jevšinek Skok, Daša, et al.
Publicado: (2019)

Expression of Cytokine-Coding Genes BMP8B, LEFTY1 and INSL5 Could Distinguish between Ulcerative Colitis and Crohn’s Disease
por: Skok, Daša Jevšinek, et al.
Publicado: (2021)

Bioinformatics Analysis Reveals Most Prominent Gene Candidates to Distinguish Colorectal Adenoma from Adenocarcinoma
por: Hauptman, Nina, et al.
Publicado: (2018)

Evaluation of Methylation Biomarkers for Detection of Circulating Tumor DNA and Application to Colorectal Cancer
por: Mitchell, Susan M., et al.
Publicado: (2016)

Total DNA methylation as a biomarker of DNA damage and tumor malignancy in intracranial meningiomas
por: Barciszewska, Anna-Maria
Publicado: (2020)

Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Hypopharynx, Larynx, Trachea and Parapharyngeal Space
por: Zidar, Nina, et al.
Publicado: (2022)

Role of Circulating Tumor DNA in Hematological Malignancy
por: Ogawa, Miho, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition in Colorectal Carcinoma: Comparison Between Primary Tumor, Lymph Node and Liver Metastases
por: Pavlič, Ana, et al.
Publicado: (2021)

Methylated circulating tumor DNA as a biomarker for colorectal cancer diagnosis, prognosis, and prediction
por: Nassar, Farah J., et al.
Publicado: (2021)

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis
por: Uesato, Yasunori, et al.
Publicado: (2020)

Diagnostic and Prognostic Characteristics of Circulating Free DNA Methylation Detected by the Electrochemical Method in Malignant Tumors
por: Sun, Li-Yue, et al.
Publicado: (2021)

Evaluation of circulating tumor DNA as a biomarker for gynecological tumors
por: Liu, Kang-Sheng, et al.
Publicado: (2020)

Circulating Tumor DNA as Biomarkers for Cancer Detection
por: Han, Xiao, et al.
Publicado: (2017)

The Clinical Landscape of Circulating Tumor DNA in Gastrointestinal Malignancies
por: Sawada, Kentaro, et al.
Publicado: (2018)

A Review of Circulating Tumor DNA in Hepatobiliary Malignancies
por: Mody, Kabir, et al.
Publicado: (2018)

Circulating Tumor DNA Testing for Liver Cancer
por: Furtado, Larissa V., et al.
Publicado: (2015)

Whole‐genome circulating tumor DNA methylation landscape reveals sensitive biomarkers of breast cancer
por: Hai, Luo, et al.
Publicado: (2022)

Genome-wide methylation analysis of circulating tumor DNA: A new biomarker for recurrent glioblastom
por: Dai, Lin, et al.
Publicado: (2023)

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC
por: Smith, Jarrod T., et al.
Publicado: (2020)

Tumor-Related Methylated Cell-Free DNA and Circulating Tumor Cells in Melanoma
por: Salvianti, Francesca, et al.
Publicado: (2016)

TMEM25 Is a Candidate Biomarker Methylated and Down-Regulated in Colorectal Cancer
por: Hrašovec, Sonja, et al.
Publicado: (2013)

Circulating tumor DNA for diagnosis, prognosis and treatment of gastrointestinal malignancies
por: Kirchweger, Patrick, et al.
Publicado: (2022)

Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer
por: Xu, Fei, et al.
Publicado: (2021)

Applying circulating tumor DNA methylation in the diagnosis of lung cancer
por: Li, Lei, et al.
Publicado: (2019)

Investigation on the potential of circulating tumor DNA methylation patterns as prognostic biomarkers for lung squamous cell carcinoma
por: Liu, Yutao, et al.
Publicado: (2020)

NPY Gene Methylation in Circulating Tumor DNA as an Early Biomarker for Treatment Effect in Metastatic Colorectal Cancer
por: Raunkilde, Louise, et al.
Publicado: (2022)

Clinical and biological significance of circulating tumor cells, circulating tumor DNA, and exosomes as biomarkers in colorectal cancer
por: Jia, Shiyu, et al.
Publicado: (2017)

Colorectal Cancer Blood-Based Biomarkers
por: Hauptman, Nina, et al.
Publicado: (2017)

In Silico Gene Prioritization Highlights the Significance of Bone Morphogenetic Protein 4 (BMP4) Promoter Methylation across All Methylation Clusters in Colorectal Cancer
por: Jevšinek Skok, Daša, et al.
Publicado: (2023)

Methylated circulating tumor DNA in blood: power in cancer prognosis and response
por: Warton, Kristina, et al.
Publicado: (2016)

Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy
por: Zhao, Xia, et al.
Publicado: (2013)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Circulating Tumor DNA—A Novel Biomarker of Tumor Progression and Its Favorable Detection Techniques
por: Wen, Xiaosha, et al.
Publicado: (2022)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_nfe5jgv09pf6qlqke1a9tg1ar5